Many common problems encountered in the ageing patient can be related to ne
uroendocrine phenomena. These include Alzheimer's disease, dementia and cog
nitive dysfunction, depression, Parkinson's disease, hyponatraemia and the
postmenopausal increase in both vascular risk and osteoporosis. This review
concentrates on the hypothalamic neuroendocrine system, including the dopa
minergic, noradrenergic, serotoninergic, cholinergic and neurohypophyseal s
ystems and the roles of the anterior pituitary and monoamine oxidases, lute
inizing hormone-releasing hormone, corticotrophin-releasing factor, the pro
-opiomelanocortin-derived and opioid peptides, peptides involved in growth
hormone and thyrotropin regulation, and amino acid transmitters.